Skip to Main Content

Muhammad Riaz, PhD, MPhil

Research Scientist
DownloadHi-Res Photo

Contact Info

Cardiovascular Medicine

300 George Street, Room # 752

New Haven, Connecticut 06511

United States

About

Titles

Research Scientist

Appointments

Other Departments & Organizations

Education & Training

Postdoctoral Associate
Yale School of Medicine (2019)
Postdoctoral fellow
Leiden University Medical Center, Leiden, the Netherlands. (2016)
PhD
Erasmus University Medical Center, Medical Oncology (2013)

Research

Overview

I am investigating biomechanical signaling and molecular mechanisms underlying cardiomyopathies including hypertrophic cardiomyopathy and amyloid cardiomyopathy (ACM). My research group routinely generates iPSCs from the peripheral blood mononuclear cells (PBMCs) of healthy individuals and patients via Sendai virus-based over-expression of Yamanaka transcription factors. This is coupled with the generation of isogenic iPSCs as control using genome editing technologies. Such patient-specific iPSCs and their corresponding isogenic controls are differentiated into functional cardiomyocytes (iPSC-CMs) for disease modeling. Using such patient-specific iPSC-CMs and through comprehensive multi-model integrative approaches including culturing patient-specific iPSC-CMs in a 2-dimensional monolayer culture system or seeding them into a decellularized scaffold of pig myocardium to construct 3-dimensional engineered heart tissue (EHTs) coupled with computational modeling, I have uncovered new mechano-transduction signaling pathway operative in heart conditions (Riaz et al Circulation 2022). Moreover, I am involved in establishing the foundation for developing innovative mechanism-based treatments for cardiovascular diseases (Ng et al JCI Insight. 2019, Park et al Acta Biomater. 2020; Luo et al Cell Stem Cell 2020; Ellis et al, J Mol Cell Cardiol. 2021; Lou et al Circulation Research 2022).

Recently, I established a genome editing facility in Qyang’s laboratory at the Yale Cardiovascular Research Center. In this facility, the clustered regularly interspaced short palindromic repeat-cas9 (CRISPR-Cas9) and the transcription activator-like effector-nuclease (TALEN) techniques are being applied to sknock in/out genetic mutations in normal or in patient-specific iPSCs to establish causal relations of the mutations with cardiovascular muscle functions (Riaz et al Circulation 2022). One of many emerging focuses of this facility is to create immunoevasive universal iPSCs for cardiovascular tissue repair and regeneration in allogeneic settings. In collaboration with Professor Al Sinusas's group at Yale University School of Medicine, I am also pursuing the regenerative potential of the iPSC-derived ISL1+ cardiovascular progenitors for ischemic heart repair in small (mouse/rat) and large (pig) preclinical models. These efforts focus on understanding the molecular basis for myocardial ischemia, angiogenesis, arteriogenesis, atrial and ventricular remodeling, and peripheral artery disease using multi-modality imaging techniques.

Medical Research Interests

Bioengineering; Cardiovascular Diseases; Regenerative Medicine; Stem Cells

Public Health Interests

Cardiovascular Diseases

Research at a Glance

Yale Co-Authors

Frequent collaborators of Muhammad Riaz's published research.

Publications

2024

2022

2021

2020

Academic Achievements & Community Involvement

  • activity

    International Food Research Journal

  • activity

    Journal of Personalized Medicine

  • activity

    International Journal of Environmental Research and Public Health

  • activity

    BioMed Central Cancer

  • activity

    Animal Genetics and Genomics

Get In Touch

Contacts

Academic Office Number
Appointment Number
Mailing Address

Cardiovascular Medicine

300 George Street, Room # 752

New Haven, Connecticut 06511

United States

Locations